Special Considerations for Child Psychiatric Trials During a Pandemic
When conducting psychiatric clinical trials with children during challenging times like a global pandemic, sponsors need specialized expertise to balance participant safety with data quality. This comprehensive white paper outlines critical considerations for adapting child psychiatric research to remote assessment environments.
Children represent a uniquely vulnerable population that requires enhanced protection during clinical research. Our expert guidance addresses the key decision points sponsors must evaluate: whether to enroll new participants, how to manage currently enrolled children, and when to transition from in-person to remote assessments.
We provide practical implementation frameworks covering safety protocols, technical requirements, and data integrity considerations specific to pediatric psychiatric assessment.
You'll also get scale-specific guidance for commonly used instruments like K-SADS-PL, CDRS-R, and CGI outlines optimal remote administration approaches that maintain measurement validity while protecting participant wellbeing.
By maintaining consistent raters, ensuring caregiver presence, and implementing appropriate technology accommodations, you can continue generating high-quality evidence even during unprecedented circumstances - always with child safety as the paramount concern.
Read the paper for the full list of recommendations.
